News
Pfizer loses appeal over use of branded painkiller pregabalin
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5578 (Published 17 October 2016) Cite this as: BMJ 2016;355:i5578- Nigel Hawkes
- London
Pfizer has failed in its bid to overturn a High Court ruling on the validity of the patents covering its painkiller pregabalin (marketed as Lyrica).
The appeal court upheld the lower court ruling against the company, in which Mr Justice Richard Arnold said that Pfizer had made “groundless claims” that its patent would be infringed unless doctors prescribed Lyrica by brand name as opposed to a generic alternative.1
Pfizer …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (inc. VAT)
You can download a PDF version for your personal record.